Prescribing NOACs in atrial fibrillation (AF)
As of 2019, novel oral anticoagulants (NOACs) are preferred over warfarin for the treatment of nonvalvular AF. Learn more about selecting the appropriate anticoagulant for your atrial fibrillation patients.
Originally termed novel oral anticoagulants because of the new or novel way that these drugs bind and inhibit factor Xa or thrombin, they are now referred to as direct oral anticoagulants, DOACs, or non-vitamin K antagonists. In this lesson, you’ll learn when to prescribe NOACs, cases where warfarin is still indicated, and how to select the best anticoagulant for your patient.
Start the first chapter of our Atrial Fibrillation Management Essentials course for free
Atrial fibrillation (AF) is the most common rhythm problem worldwide. When you see AF patients are you uncertain whether to use rhythm control or rate control, and what type of anticoagulant to prescribe? Do you wonder if your patient is a good candidate for ablation? In this course, we are going to clarify the atrial fibrillation guidelines and evidence so that you can treat AF with confidence.